Determining the role of autophagy in regulating the Staphylococcus aureus a-toxin receptor ADAM10

确定自噬在调节金黄色葡萄球菌 a-毒素受体 ADAM10 中的作用

基本信息

项目摘要

Project Summary S. aureus is responsible for a large number of infections in the community and healthcare setting. Especially as the number and incidence of antibiotic resistant strains continue to rise, the need for alternative intervention methods is becoming increasingly critical. A strategy to develop novel therapies is to identify and block host pathways exploited by pathogens to cause disease. Autophagy is one such pathway. Autophagy is a highly conserved, ubiquitous cellular process in which a double membrane autophagosome engulfs damaged cytosolic components and targets them for lysosomal degradation; however, recent research has demonstrated its critical role in pathogen tolerance and clearance. Experiments performed in collaboration between the Cadwell and Torres labs demonstrated a vital role for ATG16L1, a protein that mediates autophagosome formation, in S. aureus tolerance. Using an in vivo model of autophagy loss where ATG16L1 is almost completely abolished, the increased susceptibility to lethal challenge was found to be dependent on the production of the S. aureus virulence factor, -toxin. Upon further experimentation, it was shown that endothelial cells lacking ATG16L1 display higher levels of the plasma membrane -toxin receptor ADAM10. These data suggest autophagy plays a negative regulatory role on ADAM10. However, it is remains unclear how autophagy, a cytosolic degradation pathway, regulates the levels of membrane bound ADAM10. Our aim is to identify host factors, mechanisms, and/or pathways that are differentially regulated by autophagy that affect ADAM10 levels. Using an in vitro system that we developed for this purpose, our initial data suggests that ATG16L1 regulates ADAM10 independently of the lysosome or proteasome. Instead, cells lacking ATG16L1 show decreased production of extracellular vesicles containing ADAM10. We plan to continue to test precisely how ATG16L1 and autophagy influence native localization of ADAM10; particularly through packaging into vesicles meant for extracellular release, trafficking to the plasma membrane, and endocytic internalization. Additionally, our goal is to determine the amino acid motifs or structural elements of ADAM10 that confer its autophagy dependent regulation. Each one of these strategies is an attempt to better understand the biology of ADAM10 regulation by autophagy as this pathway and its substrates may serve as alternative targets for treatment of S. aureus infections and other conditions involving the endothelial barrier.
项目摘要 金黄色葡萄球菌负责社区和医疗保健环境中的大量感染。特别是 抗生素抗性菌株的数量和事件继续增加,需要替代干预 方法变得越来越关键。开发新疗法的策略是识别和阻止宿主 病原体探索的途径引起疾病。自噬就是这样的途径。自噬是一个高度 保守的无处不在的细胞过程,其中双膜自噬体吞噬了胞质 组件并将其靶向溶酶体降解;但是,最近的研究表明了它的关键 在病原体耐受性和清除率中的作用。 在Cadwell和Torres Labs之间合作进行的实验表明了至关重要的作用 对于ATG16L1,在金黄色葡萄球菌耐受性中介导自噬体形成的蛋白质。使用体内模型 ATG16L1几乎完全废除的自噬损失,对致命的敏感性增加 发现挑战取决于金黄色葡萄球菌病毒因子茶素的产生。进一步 实验表明,缺乏ATG16L1的内皮细胞显示出更高水平的等离子体 膜毒素受体ADAM10。这些数据表明自噬对 ADAM10。但是,尚不清楚自噬如何调节胞质降解途径 膜绑定的ADAM10。 我们的目的是确定宿主因素,机制和/或途径不同的途径。 影响ADAM10水平的自噬。使用我们为此目的开发的体外系统,我们的初始系统 数据表明ATG16L1独立于溶酶体或蛋白酶体来调节ADAM10。相反,细胞 缺乏ATG16L1显示含有ADAM10的蔬菜的产生减少。我们计划继续 精确测试ATG16L1和自噬如何影响ADAM10的本地定位;特别是通过 包装成蔬菜,用于细胞外释放,贩运到质膜和内吞细胞 内部化。此外,我们的目标是确定ADAM10的氨基酸基序或结构元素 该会议的依赖于自噬的法规。这些策略中的每一种都是试图更好地理解 ADAM10通过自噬调节的生物学,因为该途径及其底物可以作为替代方案 金黄色葡萄球菌感染和其他疾病的治疗靶标涉及内皮屏障。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

相似国自然基金

三疣梭子蟹两种含不同关键氨基酸基序C型凝集素的糖识别机制研究
  • 批准号:
    31702375
  • 批准年份:
    2017
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目
CRAC中心酪氨酸突变介导肝细胞胆小管侧膜BSEP膜胆固醇敏感性及转运功能减退的分子机制
  • 批准号:
    81670580
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目

相似海外基金

Leveraging evolutionary analyses and machine learning to discover multiscale molecular features associated with antibiotic resistance
利用进化分析和机器学习发现与抗生素耐药性相关的多尺度分子特征
  • 批准号:
    10658686
    10658686
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
    $ 3.58万
  • 项目类别:
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter baumannii
鉴定负责鲍曼不动杆菌抗性特征自然转化的宿主人类产物
  • 批准号:
    10093070
    10093070
  • 财政年份:
    2018
  • 资助金额:
    $ 3.58万
    $ 3.58万
  • 项目类别:
Ribosomally Synthesized Proteins Incorporating Modified Dipeptides
掺入修饰二肽的核糖体合成蛋白质
  • 批准号:
    9378075
    9378075
  • 财政年份:
    2017
  • 资助金额:
    $ 3.58万
    $ 3.58万
  • 项目类别:
CHARACTERIZATION OF LEGIONELLA TYPE IV SECRETION SIGNALS
IV 型军团菌分泌信号的特征
  • 批准号:
    9241342
    9241342
  • 财政年份:
    2016
  • 资助金额:
    $ 3.58万
    $ 3.58万
  • 项目类别:
DIFFERENTIATION OF ISOMERIC AMINO ACID RESIDUES IN PEPTIDES USING ECD
使用 ECD 区分肽中的异构氨基酸残基
  • 批准号:
    7955921
    7955921
  • 财政年份:
    2009
  • 资助金额:
    $ 3.58万
    $ 3.58万
  • 项目类别: